Title |
Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis
|
---|---|
Published in |
World Journal of Surgical Oncology, May 2012
|
DOI | 10.1186/1477-7819-10-75 |
Pubmed ID | |
Authors |
Sudheer R Thumma, Robert K Fairbanks, Wayne T Lamoreaux, Alexander R Mackay, John J Demakas, Barton S Cooke, Ameer L Elaimy, Peter W Hanson, Christopher M Lee |
Abstract |
Glioblastoma Multiforme (GBM) is one of the most aggressive primary brain tumors and is associated with a dismal prognosis. The median survival after the primary diagnosis remains poor, even after multimodal treatment approaches. However, a few patients have been reported to have long term survival greater than three years. A number of studies have attempted to define factors capable of predicting long term outcomes in specific patient groups. This article reports the outcomes of a very large group of patients diagnosed with GBM, and analyzes specific prognostic factors known to influence survival in these patients. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 1 | 2% |
Brazil | 1 | 2% |
Unknown | 47 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 8 | 16% |
Researcher | 7 | 14% |
Student > Ph. D. Student | 7 | 14% |
Student > Doctoral Student | 6 | 12% |
Student > Bachelor | 5 | 10% |
Other | 7 | 14% |
Unknown | 9 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 22 | 45% |
Neuroscience | 5 | 10% |
Agricultural and Biological Sciences | 3 | 6% |
Biochemistry, Genetics and Molecular Biology | 2 | 4% |
Nursing and Health Professions | 2 | 4% |
Other | 4 | 8% |
Unknown | 11 | 22% |